rockrziq.at first i was neutral.u need to read from the very beginning. NPRA blamed me for giving contra direction.
That is not about chart pattern,it is about the whole technical chart.1 broker houese issue buying called but only if it passed 21.5 cents same as my technical view.
so many came out and comment kena conned by vaccine dream at here. Never mind lah it is just a dream. you still have bamboo dream. Always remember the director is greedy one. He will be greedy again one. ESOs another 20% that is over 500m shares and the director given an option of 100mil at 16sen. Just see when he want to excercise it lah. After all he is still a greedy o.ne lah. Correct?
where are the 2 jokers keep say con ctr one. no bamboo no vacvine and only with toilet paper one. another one also said no vaccine but ada bamboo one and worth only 10sen one. still wtg 10sen? are you hiding in your cave now? Correct?
ENOUGH ULARSAWA. U IN FGV ALSO MADE ALOT OF IMMATURE NOISE AND COMMENTS. PLEASE KEEP THE HARMONY. OTHER PEOPLE CON JOB THEIR BUSINESS. U KEEP THE POSITIVENESS HERE.
Actually I m here is antivac and promote bamboo dream. Not anti kanger that much. after all many kena conned with vaccine dream. not their fault also. only fault is dream too much about vaccine promoted by vaccine fanatic at here. most of the vaccine fanatic already gone. left bamboo dreamer still stay back lah. Correct?
if kanger not bamboo ctr. why build new bamboo plant worth over rm100 mil. If really con ctr. why Nur sit on top as chairman. Think logic abit lah. will he take the risk. risk his reputation to join con ctr just to earn director fee. Correct?
I think this quarrel about vaccine or bamboo should stop. It litters this forums with unnecessary reading material. If only you people is as hardworking to seek fundamental reports or technical studies of this counter, and share it, then it will be somewhat more productive and useful.
What a contrast in news reports – Singapore received its first batch of Pfizer’s Covid-19 vaccine while Malaysian Prime Minister only signing agreement with AstraZeneca for an additional 6.4 million doses of Covid-19 vaccine
(Tatal ke bawah untuk kenyataan versi BM)
What a contrast in news reports – Singapore received its first batch of Pfizer’s Covid-19 vaccine while Malaysian Prime Minister, Tan Sri Muhyiddin Yassin only signing agreement with pharmaceutical company AstraZeneca for an additional 6.4 million doses of Covid-19 vaccine.
Singapore is the first Asian country to receive the Pfizer-BioNTech shots after it said last week that it had approved the companies’ vaccine and is expected to begin a widespread vaccination programme in the first week of January with the aged and priority work first, and a target to vaccinate the entire population of 5.3 million as soon as possible.
Malaysia? The Prime Minister has just signed agreement for the procurement of an additional 10 percent or 6.4 million doses of the Covid-19 vaccine for 40 percent of the population through Covax, Pfizer and AstraZeneca.
I thank the Science, Technology and Innovation Minister, Khairy Jamaluddin for inviting me to his post-Cabinet press conference tomorrow on the pricing of Pfizer’s Covid-19 vaccine.
I am not in Kuala Lumpur and will not be in Putrajaya for his press conference, especially as I believe that Malaysian journalists are among the best in the world and can handle Khairy’s press conference.
Let Khairy tell Malaysians the pricing difference between Malaysia’s procurement of Covid-19 vaccine with other countries like Belgium and Singapore.
And even more important, let Khairy announce that the vaccine will be free for all Malaysians.
However, if the Prime Minister, Tan Sri Muhyiddin Yassin is prepared to hold a press conference or a special function to announce that the government is finally prepared to adopt an “all-of-government” and “whole-of-society” strategy and approach in the war against the third wave of Covid-19 pandemic, and the new measures in this strategy and approach, I will make myself available for Muhyiddin’s announcement if invited.
The US-based Institute for Health Metrics Evaluation (IHME) projects a continuous rise in Covid-19 cases until mid-March 2021, hitting over 5,000 infections daily at the end of February.
If the IHME model is proved right, then Malaysia will join the top 30 countries in the world with the most rapid surge in Covid-19 infections, as there are less than 25 countries in the world which register a daily increase of 5,000 Covid-19 infections.
On Dec. 17, Malaysia overtook China with more cumulative total of Covid-19 cases, exchanging places with China in the ranking of countries with most cumulative total of Covid-19 cases – Malaysia No. 79 and China No. 80.
Yesterday, on Dec. 21, we surged forward in Covid-19 infections and is now ranked No. 76 in the world, having overtaken three more countries, i.e. Bahrain, Kenya and Libya after registering 2,018 new Covid-19 cases, bringing the nation’s cumulative total to 95,327 cases.
Malaysia is set to overtake more countries, in a trajectory to join the world’s top 30 countries with the most number of Covid-19 cases – a sure and serious sign of the Malaysia’s fast decline to a failed state.
Malaysians are increasingly concerned about the government’s response to the Covid-19 pandemic, not just the procurement, prices and safety of Covid-19 vaccine but why the government is shying away from an “all-of-government” and “whole-of-society” strategy and approach to bring the third wave of the Covid-19 pandemic in Malaysia under control.
(Media Statement by DAP MP for Iskandar Puteri Lim Kit Siang in Gelang Patah on Tuesday, 22nd December 2020)
Govt considering Sinovac good la . So Sinopharm can be on private use only, lagi bagus. Only need someone apply for the Sinopharm approval and be the distributor.
But better hope long term progress from bamboo and real estate income . Bonus is sand biz , then gambling on Glove ( land bought or not still no news ) and Vaccine . Both ventures PP already collection cash .
Kanger International Bhd has proposed a private placement of up to 386.97 million shares to raise RM68.88 million, to be used for working capital and future investment.
Kanger International - core business = Producer of Bamboo products.
Covid 19 Vaccine Business = Distributor of Covid-19 vaccines and medical equipment products in Malaysia for China Sinopharm Group Hunan Changde Medical Co. Ltd (SGHC). Also signed an MoU Zuellig Pharma to facilitate the import, warehousing and distribution of Covid-19 vaccines. so market capitalization is about @RM372.12Mil.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
rockrziq
181 posts
Posted by rockrziq > 2020-12-23 00:26 | Report Abuse
it's not easy to bankrupt. Look at other major shareholders still steady. Even Sultan Perlis still there.